Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis

被引:128
|
作者
Ikeda, S [1 ]
Ushio-Fukai, M [1 ]
Zuo, L [1 ]
Tojo, T [1 ]
Dikalov, S [1 ]
Patrushev, NA [1 ]
Alexander, RW [1 ]
机构
[1] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA
关键词
ARF6; caveolin; vascular endothelial growth factor; endothelial cell; angiogenesis;
D O I
10.1161/01.RES.0000158286.51045.16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor ( VEGF) stimulates endothelial cell (EC) migration and proliferation primarily through the VEGF receptor-2 (VEGFR2). We have shown that VEGF stimulates a Rac1-dependent NAD(P)H oxidase to produce reactive oxygen species (ROS) that are involved in VEGFR2 autophosphorylation and angiogenic-related responses in ECs. The small GTPase ARF6 is involved in membrane trafficking and cell motility; however, its roles in VEGF signaling and physiological responses in ECs are unknown. In this study, we show that overexpression of dominant-negative ARF6 [ARF6(T27N)] almost completely inhibits VEGF-induced Rac1 activation, ROS production, and VEGFR2 autophosphorylation in ECs. Fractionation of caveolae/lipid raft membranes demonstrates that ARF6, Rac1, and VEGFR2 are localized in caveolin-enriched fractions basally. VEGF stimulation results in the release of VEGFR2 from caveolae/lipid rafts and caveolin-1 without affecting localization of ARF6, Rac1, or caveolin-1 in these fractions. The egress of VEGFR2 from caveolae/lipid rafts is contemporaneous with the tyrosine phosphorylation of caveolin-1 (Tyr14) and VEGFR2 and with their association with each other. ARF6(T27N) significantly inhibits both VEGF-induced responses. Immunofluorescence studies show that activated VEGFR2 and phosphocaveolin colocalize at focal complexes/ adhesions after VEGF stimulation. Both overexpression of ARF6(T27N) and mutant caveolin1(Y14F), which cannot be phosphorylated, block VEGF-stimulated EC migration and proliferation. Moreover, ARF6 expression is markedly upregulated in association with an increase in capillary density in a mouse hindlimb ischemia model of angiogenesis. Thus, ARF6 is involved in the temporal-spatial organization of caveolae/lipid rafts- and ROS-dependent VEGF signaling in ECs as well as in angiogenesis in vivo.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 50 条
  • [1] Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
    Seo, Songyi
    Kim, Mi-Kyung
    Kim, Ryul-, I
    Yeo, Yeongju
    Kim, Koung Li
    Suh, Wonhee
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (10): : 1744 - 1753
  • [2] Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
    Songyi Seo
    Mi-Kyung Kim
    Ryul-I Kim
    Yeongju Yeo
    Koung Li Kim
    Wonhee Suh
    Experimental & Molecular Medicine, 2020, 52 : 1744 - 1753
  • [3] In vivo assessment of vascular endothelial growth factor-induced angiogenesis
    Lewin, M
    Bredow, S
    Sergeyev, N
    Marecos, E
    Bogdanov, A
    Weissleder, R
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (06) : 798 - 802
  • [4] Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
    Fukumura, D
    Gohongi, T
    Kadambi, A
    Izumi, Y
    Ang, J
    Yun, CO
    Buerk, DG
    Huang, PL
    Jain, RK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2604 - 2609
  • [5] Genetic loci that control vascular endothelial growth factor-induced angiogenesis
    Rogers, MS
    Rohan, RM
    Birsner, AE
    D'Amato, RJ
    FASEB JOURNAL, 2003, 17 (12): : 2112 - +
  • [6] Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo
    Xin, XH
    Yang, SY
    Ingle, G
    Zlot, C
    Rangell, L
    Kowalski, J
    Schwall, R
    Ferrara, N
    Gerritsen, ME
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03): : 1111 - 1120
  • [7] Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro
    Tille, JC
    Pepper, MS
    EXPERIMENTAL CELL RESEARCH, 2002, 280 (02) : 179 - 191
  • [8] ENDOGLIN Is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis
    Liu, Zhen
    Lebrin, Franck
    Maring, Janita A.
    van den Driesche, Sander
    van der Brink, Stieneke
    van Dinther, Maarten
    Thorikay, Midory
    Martin, Sabrina
    Kobayashi, Kazuki
    Hawinkels, Lukas J. A. C.
    van Meeteren, Laurens A.
    Pardali, Evangelia
    Korving, Jeroen
    Letarte, Michelle
    Arthur, Helen M.
    Theuer, Charles
    Goumans, Marie-Jose
    Mummery, Christine
    ten Dijke, Peter
    PLOS ONE, 2014, 9 (01):
  • [9] Vascular endothelial growth factor-induced angiogenesis: Crouching tiger or hidden dragon?*
    Losordo, DW
    Isner, JM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (08) : 2131 - 2135
  • [10] Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells
    Wang, Liangjun
    Chen, Ning
    Cheng, Hongxia
    ONCOLOGY LETTERS, 2020, 20 (02) : 1239 - 1244